SGMO Financial Facts

Research grants: 820K
Total revenues: 13.49M
See Full Income Statement

Total current liabilities: 19.97M
Total stockholders' equity: 207.49M
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 8/5/15 EPS Growth Rate -30.0%
Average EPS % Beat Rate +31.5% Revenue Growth Rate +41.5%
Average % Move 1-Wk after EPS +6.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/15 Q215 N/A-$0.13 N/A N/A$14.72M = N/A N/A
4/22/15 Q115 -$0.08-$0.14 +$0.06$13.5M$12.5M = Details
2/10/15 Q414 -$0.06-$0.09 +$0.03$14.95M$14.5M = Details
10/22/14 Q314 -$0.11-$0.14 +$0.03$12.4M$8.27M = Details
7/23/14 Q214 -$0.10-$0.14 +$0.04$10.4M$7.84M = Details
5/6/14 Q114 -$0.12-$0.13 +$0.01$8.1M$6.59M = Details
2/11/14 Q413 -$0.13N/A N/A $6.9M$8.9M = Details
10/23/13 Q313 -$0.11-$0.11 $0.00$5.7M$5.52M = Details